Articles in Stocks

Zacks.com

Is Align Technology (ALGN) Worth Adding to Your Portfolio? - Analyst Blog

On Sep 23, Zacks Investment Research upgraded Align Technology ( ALGN ) to a Zacks Rank #2 (Buy). Why the Upgrade? Align posted a mixed second quarter 2014 where earnings per share topped the... Read >>

Motley Fool

3 Reasons Why Microsoft Is a Top Dividend Stock

Last week, Microsoft investors were treated to another dividend increase. This time the company raised its per share payout from $0.28 to $0.31 per quarter good for a 10.7% increase. Oddly... Read >>

Zacks.com

TripAdvisor (TRIP) Down on Viator Data Breach Concerns - Analyst Blog

Following news of a data breach at TripAdvisor 's ( TRIP ) recent acquisition, Viator, the travel information company's shares declined more than 4% to $94.29. Viator revealed that approximately... Read >>

Zacks.com

Terex (TEX) Hits 52-Week Low Following Trimmed Guidance - Analyst Blog

Shares of Terex Corp. ( TEX ) hit a 52 week low of $31.85 yesterday follwing the company's trimmed fiscal 2014 guidance due to weak crane demand. Shares of this Zacks Rank #4 (Sell) stock closed a... Read >>

Zacks.com

Anacor's Kerydin Launched in the US for Onychomycosis - Analyst Blog

Anacor Pharmaceuticals, Inc. ( ANAC ) announced that its Kerydin topical solution, 5% has been launched in the U.S. by partner Sandoz Inc., a Novartis ( NVS ) company. Kerydin is the first FDA... Read >>

Zacks.com

Dynavax (DVAX) Completes Enrolment for Study on Heplisav - Analyst Blog

Dynavax Technologies Corporation ( DVAX ) announced that it completed the planned enrolment in the ongoing clinical trial, HBV 23, on experimental hepatitis B vaccine, Heplisav B. We note that in... Read >>

Zacks.com

Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog

Supernus Pharmaceuticals, Inc. ( SUPN ) reaffirmed its 2014 guidance (announced on the second quarter 2014 earnings call) assuring that it will emerge profitable by year end. The company also... Read >>

Zacks.com

Citigroup Seeks U.S. Judge to Halt Argentine Bond Order - Analyst Blog

Caught between the Argentina government and a U.S. court order, Citigroup Inc. ( C ) is struggling for some reprieve. The bank is seeking U.S. District Judge Thomas Griesa to permit it to make... Read >>

Motley Fool

Google Enlists Japanese and Korean Game Makers to Strike Back Against Apple

Google is looking toward mobile gaming markets in Japan and Korea to boost Google Play revenue, according to a recent Bloomberg report. Google will increase support for Japanese publishers like... Read >>

Zacks.com

Bayer/Regeneron Successfully Expand Eylea Label in Japan - Analyst Blog

The HealthCare segment at Bayer ( BAYRY ) announced that its blockbuster eye treatment, Eylea, was approved for yet another indication in Japan. The drug was approved by the Ministry of Health,... Read >>